TELA Bio, Inc. (TELA) Stock Analysis
A live, multi-source view of TELA Bio, Inc. (TELA): real-time price, technical indicators, Wall Street analyst consensus, recent news sentiment and social buzz — aggregated into one place so you can size up the stock at a glance.
About TELA Bio, Inc.
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene, polyglycolic acid, and polylactic-co-glycolic acid designed to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
Sector: Healthcare · Industry: Medical Devices · United States · 218 employees · telabio.com
Key statistics · as of 2026-09-06
As of 2026-09-06, TELA Bio, Inc. (TELA) had a market capitalization of $36.9M (forward -1.8) and a beta of 1.36; the shares traded in a 52-week range of $0.50 – $1.73 (-49.3% over the year).
- Market cap
- $36.9M
- Enterprise value
- $64.4M
- Forward P/E
- -1.8
- EPS (trailing)
- $-0.77
- EPS (forward)
- $-0.46
- Payout ratio
- 0.0%
- 52-week range
- $0.50 – $1.73
- 52-week change
- -49.3%
- Beta
- 1.36
- Average volume
- 168,566
- Shares outstanding
- 44.9M
- Short % of float
- 1.09%
- Profit margin
- -51.5%
Fundamental figures are recorded once every few days, dated above; they are not live and can differ from the interactive tiles.
Last universe scan · 2026-09-10
In RapidTradeView’s 2026-09-10 scan of the US universe, TELA Bio, Inc. (TELA) last closed at $0.91 (the last completed close before that scan).
Technicals at the scan: RSI 67 (neutral territory), price +28.3% versus its 20-day average, 20-day versus 50-day average spread -5.3%, MACD histogram 0.02.
Sentiment inputs: StockTwits 94% bullish; analyst consensus score 75/100.
Next scheduled company event: in 63 days from the scan date.
Scan values are recorded once per trading day and are not live quotes; the interactive tiles above update in real time.
Smart Money · last 90 days
Members of Congress disclosed 0 buys and 0 sells of TELA; corporate insiders filed 2 buys and 0 sells (1 filer, latest disclosure 2026-08-19). Filings arrive days to weeks after the trade and are not a live signal. Most active filers: Heather C. Getz (2B/0S). Who is trading what
RapidTradeView pick record
TELA has not appeared in the daily picks yet. Full scoreboard
What this page covers
RapidTradeView pulls TELA Bio, Inc. (TELA) data from multiple independent sources and combines it into a single dashboard. Below the summary you’ll find live, interactive tiles for each of the following:
- Price & chart — real-time quote with pre/post-market moves and a line or candlestick chart.
- Technical indicators — RSI, MACD, moving averages, Bollinger Bands, volume and support/resistance, distilled into one overall signal.
- Analyst consensus — the buy/hold/sell breakdown and price targets published by Wall Street analysts.
- News sentiment — recent headlines, each scored for tone so the prevailing narrative is obvious.
- Earnings — current EPS, year-over-year change and the next scheduled earnings date.
- Social buzz — Reddit mention volume and StockTwits sentiment for the retail-trader angle.
How to read the signals
No single indicator tells the whole story. A bullish technical reading paired with a cautious analyst consensus, or strong social buzz against weak earnings, is exactly the kind of tension this view is built to surface. RapidTradeView’s signals are generated by deterministic, statistical models — they describe what the data is doing, they are not personalised recommendations to buy or sell TELA.
Disclaimer: RapidTradeView is an educational sentiment-aggregation tool, not a licensed financial adviser, broker, or dealer. Nothing here is financial, investment, tax, or legal advice. Markets are risky and you can lose money. Always do your own research and consult a qualified professional before making any investment decision.